Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Filippi

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Cancer Investigation|November 27, 2024
Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive SignificanceRoberto Filippi, Giovanni Brandi, Andrea Casadei-Gardini, et al.
Clinical Genitourinary Cancer|April 17, 2024
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27Marco Stellato, Sebastiano Buti, Marco Maruzzo, et al.
Cancers|November 26, 2022
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort StudyStefano Granieri, Christian Cotsoglou, Alessandro Bonomi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2019
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validationsCindy Neuzillet, Andrea Casadei Gardini, Bertrand Brieau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2019
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancerMassimiliano Salati, Roberto Filippi, Caterina Vivaldi, et al.
Oncology|February 24, 2021
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma PatientsAndrea Casadei-Gardini, Roberto Filippi, Margherita Rimini, et al.
The Oncologist|February 17, 2018
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyValentina Fanotto, Mario Uccello, Irene Pecora, et al.
The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.
The Oncologist|September 2, 2017
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyValentina Fanotto, Mario Uccello, Irene Pecora, et al.
Clinical Genitourinary Cancer|October 5, 2023
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective AnalysisChiara Pisano, Fabio Turco, Elena Arnaudo, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Cancer Investigation|November 27, 2024
Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive SignificanceRoberto Filippi, Giovanni Brandi, Andrea Casadei-Gardini, et al.
Clinical Genitourinary Cancer|April 17, 2024
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27Marco Stellato, Sebastiano Buti, Marco Maruzzo, et al.
Cancers|November 26, 2022
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort StudyStefano Granieri, Christian Cotsoglou, Alessandro Bonomi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2019
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validationsCindy Neuzillet, Andrea Casadei Gardini, Bertrand Brieau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2019
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancerMassimiliano Salati, Roberto Filippi, Caterina Vivaldi, et al.
Oncology|February 24, 2021
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma PatientsAndrea Casadei-Gardini, Roberto Filippi, Margherita Rimini, et al.
The Oncologist|February 17, 2018
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyValentina Fanotto, Mario Uccello, Irene Pecora, et al.
The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.
The Oncologist|September 2, 2017
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyValentina Fanotto, Mario Uccello, Irene Pecora, et al.
Clinical Genitourinary Cancer|October 5, 2023
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective AnalysisChiara Pisano, Fabio Turco, Elena Arnaudo, et al.
Pageof 6